Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008-2024).

Abdelmoteleb S, Totlani J, Ramadan S, Salem M, Meyer A, Chang T, Ewing M, Freire L, Murphy N, Renteria S, Dymkoski R, Liran O, Hedrick R, Danovitch I, Pechnick RN, IsHak WW

Open source

DOI: 10.1016/j.nsa.2025.105507
Published: 2025
Container: Neuroscience applied
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.nsa.2025.105507,
  title = {Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008-2024).},
  author = {Abdelmoteleb S and Totlani J and Ramadan S and Salem M and Meyer A and Chang T and Ewing M and Freire L and Murphy N and Renteria S and Dymkoski R and Liran O and Hedrick R and Danovitch I and Pechnick RN and IsHak WW},
  year = {2025},
  journal = {Neuroscience applied},
  doi = {10.1016/j.nsa.2025.105507},
  url = {https://doi.org/10.1016/j.nsa.2025.105507}
}

RIS

TY  - JOUR
TI  - Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008-2024).
AU  - Abdelmoteleb S
AU  - Totlani J
AU  - Ramadan S
AU  - Salem M
AU  - Meyer A
AU  - Chang T
AU  - Ewing M
AU  - Freire L
AU  - Murphy N
AU  - Renteria S
AU  - Dymkoski R
AU  - Liran O
AU  - Hedrick R
AU  - Danovitch I
AU  - Pechnick RN
AU  - IsHak WW
PY  - 2025
JO  - Neuroscience applied
DO  - 10.1016/j.nsa.2025.105507
UR  - https://doi.org/10.1016/j.nsa.2025.105507
ER  -

APA

S, A., J, T., S, R., M, S., A, M., T, C., M, E., L, F., N, M., S, R., R, D., O, L., R, H., I, D., RN, P., & WW, I. (2025). Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008-2024).. Neuroscience applied. https://doi.org/10.1016/j.nsa.2025.105507

Source records

pubmed · retrieved 2026-09-25T08:53:48.356Z